Our most recent contribution was in the form of a scientific session entitled The rise and rise of Biotherapeutics (APS International PharmSci, September 2017), where we looked at the science of large molecules as medicines, large scale manufacturing and delivery and a joint session at the same conference with the Material Science and the Joint Pharmaceutical Analysis Group.
We have identified the following as areas of significant scientific interest:
1. Novel characterisation tools and control strategy for biotherapeutics.
2. Challenges for the use of an effective manufacturing process for biotherapeutics
3. Biosimilars – bioequivalence, formulation and methods of delivery.
4. Acceleration of the development of biotherapeutics to market.
Lead a session at the APS annual conference entitled “Multi-attribute testing of biopharmecuticals” jointly with Parenterals Focus Group.
Develop workshop entitled “Gene therapy: from concept to delivery” with contributions from other focus group members.
Secure sponsorship for Essay competition entitled Towards patient centred biotherapeutics
Develop workshop entitled “Developability of biotherapeutics”